Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-11-19
1989-08-15
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514405, A61K 31415
Patent
active
048575429
ABSTRACT:
A prophylactic and therapeutic agent for circulatory disorders, comprising a pyrazolone derivative of the formula: ##STR1## wherein R.sub.1 represents a hydrogen atom, an aryl group, an alkyl group having 1 to 5 carbon atoms or an alkoxycarbonylalkyl group having a total carbon number of 3 to 6; R.sub.2 represents a hydrogen atom, an aryloxy group, an arylmercapto group, an alkyl group having 1 to 5 carbon atoms or hydroxyalkyl group having 1 to 3 carbon atoms; or R.sub.1 and R.sub.2 taken together represent an alkylene group having 3 to 5 carbon atoms; R.sub.3 represents a hydrogen atom, an alkyl group having 1 to 5 carbon atoms, a cycloalkyl group having 5 to 7 carbon atoms, a hydroxyalkyl group having 1 to 3 carbon atoms, a benzyl group, a naphthyl group, or a phenyl group which is unsubstituted or substituted with 1 to 3 substituents which are the same or different selected from the group consisting of alkyl groups having 1 to 5 carbon atoms, alkoxy groups having 1 to 5 carbon atoms, hydroxyalkyl groups having 1 to 3 carbon atoms, alkoxycarbonyl groups having total carbon number of 2 to 5, alkylmercapto groups having 1 to 3 carbon atoms, alkylamino groups having 1 to 4 carbon atoms, dialkylamino groups having total carbon number of 2 to 8, halogen atoms, trifluoromethyl group, carboxyl group, cyano group, hydroxyl group, nitro group, amino group and acetamide group,
or a pharmaceutically acceptable salt thereof as an acitve ingredient.
The agent of the present invention is useful as a prophylactic and therapeutic agent for circulatory disorders, particularly as an inhibitor agaisnt lipid peroxidation and/or an agent for normalizing cerebral dysfunctions.
REFERENCES:
patent: 3514465 (1970-05-01), Posselt et al.
patent: 3658845 (1972-04-01), Posselt et al.
patent: 3781439 (1973-12-01), Zoni et al.
patent: 4000294 (1976-12-01), Moller et al.
patent: 4005215 (1977-01-01), Moller et al.
patent: 4053621 (1977-10-01), Moller et al.
patent: 4112227 (1978-09-01), Moller et al.
patent: 4288446 (1981-09-01), Moller et al.
patent: 4670460 (1987-06-01), Mardin et al.
patent: 4698344 (1987-10-01), Sasse et al.
Chem. Abst. 73:45404h, (1970)-Williams et al.
Chem. Abst. 101:222712(b), (1984)-Mardin et al.
Chem. Abst. 102:17649r, (1985)-Moeller et al.
Chem. Abst. 102:56154v, (1985)-Bayer A.G.
"Stroke", vol. 8, No. 1, Jan.-Feb. 1977, pp. 51-57.
"Cardiovascular Research", 14, 1980, pp. 371-395.
Iseki Katsuhiko
Morinaka Yasuhiro
Nishi Hiroyoshi
Sakurai Hiroko
Watanabe Toshiaki
Mitsubishi Chemical Industries Limited
Waddell Frederick E.
LandOfFree
Prophylactic and therapeutic composition for circulatory disorde does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prophylactic and therapeutic composition for circulatory disorde, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prophylactic and therapeutic composition for circulatory disorde will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-121966